- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 11.17M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $22.99M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $22.39M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $7.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $8.2M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $6.41M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $28.45M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $26.51M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $49.26M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $46.79M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $21.17M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $20.07M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $58.58M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $58.44M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 9.3M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.18M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $20.27M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $19.96M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.98M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$326.77K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $164.54K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.32M |